Skip to main content
Clinical Trials/NCT06261736
NCT06261736
Recruiting
Not Applicable

The Effectiveness of Prophylactic Antibiotics for Urethral Bulking

Atlantic Health System1 site in 1 country70 target enrollmentOctober 24, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stress Urinary Incontinence
Sponsor
Atlantic Health System
Enrollment
70
Locations
1
Primary Endpoint
Rate of urinary tract infection (UTI)
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The goal of this clinical trial is to evaluate if prophylactic antibiotics in urethral bulking are effective in reducing postprocedural urinary tract infections.

Detailed Description

Urethral bulking is a minimally invasive surgical treatment option for stress urinary incontinence (SUI). One commonly reported post-procedural complication is urinary tract infection (UTI). UTI rates are variable where studies have reported rates from as low as 0% to as high as 40%. Along with this variability, the instructional inserts for various bulking agents have inconsistent recommendations for use of prophylactic antibiotics. The American Urologic Association recommends antimicrobial prophylaxis for cystourethroscopy procedures involving minor manipulation. Currently, there are no clear guidelines regarding the utility of prophylactic antibiotics for urethral bulking. The objective of our study is to determine the effectiveness of prophylactic antibiotics in urethral bulking for reducing post procedural UTIs.

Registry
clinicaltrials.gov
Start Date
October 24, 2023
End Date
January 2026
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Erika Wasenda

MD

Atlantic Health System

Eligibility Criteria

Inclusion Criteria

  • Patients scheduled to undergo a urethral bulking procedure
  • Age 18 ≥ over

Exclusion Criteria

  • History of recurrent urinary tract infections
  • Known history of urinary retention
  • Allergies or contraindications to multiple antibiotics
  • Inability to tolerate oral antibiotics
  • Concomitant surgical procedures at the time of urethral bulking
  • Pregnant or breastfeeding

Outcomes

Primary Outcomes

Rate of urinary tract infection (UTI)

Time Frame: Within 4 weeks after the procedure

The rate of UTI based on symptoms and a positive urine culture

Secondary Outcomes

  • Rates of other postoperative complications(Within 4 weeks after the procedure)
  • Rate of postoperative urinary retention(Within 4 weeks after the procedure)

Study Sites (1)

Loading locations...

Similar Trials